Johnson & Johnson Innovation

Established in 1973, Johnson & Johnson Innovation facilitates early-stage innovation through strategic partnerships. It connects potential collaborators with resources to advance transformative science and technology across pharmaceuticals, medical devices, and consumer healthcare sectors.

http://www.jnjinnovation.com

https://crunchbase.com/organization/***

https://linkedin.com/company/***

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=21299

Maciek Drozdz

Principal of Venture Investments

V.Kadir Kadhiresan

Vice President, Venture Investments

Sanjay Mistry

Vice President, Venture Investments, New Company Creation

Chris Picariello

President

Elizabeth Wu

Director, Early Innovation Partnering

Past deals in South Carolina

Neuroene Therapeutics

Grant in 2024

Neuroene Therapeutics is a startup biotechnology company developing novel Vitamin K-based therapeutics for neurological disorders such as epilepsy. The company originated from collaborative research between Medical University of South Carolina investigators C. James Chou, Ph.D., and Sherine Chan, Ph.D., who cofounded and continue to lead Neuroene Therapeutics.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.